California Stem Cell, Inc. announced today that the U.S. Food and Drug Administration has approved the CompanyA's application to begin a Phase II clinical trial exploring the potential of a patient-specific cancer immunotherapy in women with Stage III or IV ovarian, fallopian tube or primary peritoneal cancer.
http://ift.tt/1eOULXD
http://ift.tt/1eOULXD
No comments:
Post a Comment